WWW.TANDBLEGEKLINIKKEN.DK ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  14.6% 20.6% 17.4% 14.4% 15.6%  
Credit score (0-100)  15 5 8 14 11  
Credit rating  BB B B BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  16.1 -4.7 -2.7 -0.2 -0.3  
EBITDA  16.1 -4.7 -2.7 -0.2 -0.3  
EBIT  16.1 -4.7 -2.7 -0.2 -0.3  
Pre-tax profit (PTP)  21.4 0.4 2.6 4.3 4.7  
Net earnings  17.4 0.2 2.0 3.4 3.6  
Pre-tax profit without non-rec. items  21.4 0.4 2.6 4.3 4.7  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  190 191 193 128 129  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  212 204 197 129 130  

Net Debt  -32.2 -24.4 -0.3 0.0 -0.0  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  16.1 -4.7 -2.7 -0.2 -0.3  
Gross profit growth  0.0% 0.0% 43.6% 94.2% -128.8%  
Employees  1 0 0 0 0  
Employee growth %  0.0% -100.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  212 204 197 129 130  
Balance sheet change%  14.9% -3.5% -3.7% -34.3% 0.3%  
Added value  16.1 -4.7 -2.7 -0.2 -0.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  10.9% 0.3% 1.4% 2.7% 3.6%  
ROI %  11.8% 0.3% 1.4% 2.8% 3.6%  
ROE %  9.6% 0.1% 1.1% 2.1% 2.8%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  89.8% 93.2% 97.8% 99.3% 99.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -199.5% 518.2% 11.0% -3.9% 11.4%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  191.7% 0.0% 0.0% 3,200.0% 100.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  9.8 14.6 45.6 135.3 125.9  
Current Ratio  9.8 14.6 45.6 135.3 125.9  
Cash and cash equivalent  32.2 24.4 0.3 0.0 0.0  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  190.3 190.5 192.5 128.4 128.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  16 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  16 0 0 0 0  
EBIT / employee  16 0 0 0 0  
Net earnings / employee  17 0 0 0 0